Zoetis Shares Fall After FDA Notice to Librela (ZTS:NYSE)


Zoetis facility in Kalamazoo, MI, USA

Editorial JHVEPhoto/iStock via Getty Images

Zoetis shares (NYSE:ZTS) traded lower on Tuesday after the US FDA notified veterinarians of adverse events related to the company’s pain therapy, Librela (bedinvetmab injection), indicated for dogs.

In a “Dear Veterinarian” letter Monday, the agency noted that adverse events like



Source link

  • Related Posts

    Client Challenge

    Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to continue. A required part of this site could not load. This could be due to a browser extension,…

    The German economy is expected to grow by 0.3% in the fourth quarter

    The German economy is expected to grow by 0.3% in the fourth quarter Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *